Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Guo
KDR Activating Mutations in Human Angiosarcomas Are Sensitive to Specific Kinase Inhibitors
Cancer Research
Cancer Research
Oncology
Interfacial Area and Interfacial Transfer in Two-Phase Flow Systems (Volume III. Chapters 11-14)
‹
1
2
Related publications
How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations
OncoTargets and Therapy
Oncology
Pharmacology
Phosphatidylinositol 3-Kinase Mutations Identified in Human Cancer Are Oncogenic
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Oncogenic JAK1 and JAK2-activating Mutations Resistant to ATP-competitive Inhibitors
Haematologica
Hematology
Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Influence of EGFR-activating Mutations on Sensitivity to Tyrosine Kinase Inhibitors in a KRAS Mutant Non-Small Cell Lung Cancer Cell Line
PLoS ONE
Multidisciplinary
Phosphoinositide 3-Kinase Mutations in Breast Cancer: A "Good" Activating Mutation?
Clinical Cancer Research
Cancer Research
Oncology
Functional Genomics Reveals That Tumors With Activating Phosphoinositide 3-Kinase Mutations Are Dependent on Accelerated Protein Turnover
Genes and Development
Genetics
Developmental Biology
Kinase Domain Mutations Confer Resistance to Novel Inhibitors Targeting JAK2V617F in Myeloproliferative Neoplasms
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology